Resource Summary

Clinical Question:
What are the benefits and harms of cholinesterase inhibitors (ChEI) for Alzheimers dementia?

Bottom-line:
Evidence for ChEI in Alzheimers dementia is generally limited by small differences and high drop-out rates. Approximately one in ten patients show meaningful clinical improvement when treated for six months and -1 in ten patients stop using the drug due to an adverse event.


*** Original Documents can be found and downloaded using the link provided below ***

https://www.acfp.ca/tools-for-practice/

Publication Date: 2014-2-18
Last Updated on PCR: 2017-03-31 14:45:23